Online citations, reference lists, and bibliographies.
← Back to Search

The C-Reactive Protein/Albumin Ratio Is A Novel Significant Prognostic Factor In Patients With Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study

Shinkichi Takamori, G. Toyokawa, M. Shimokawa, Fumihiko Kinoshita, Y. Kozuma, T. Matsubara, Naoki Haratake, Takaki Akamine, F. Hirai, T. Seto, T. Tagawa, M. Takenoyama, Y. Ichinose, Y. Maehara
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BackgroundMalignant pleural mesothelioma (MPM), a devastating neoplasm, is traditionally considered to be resistant to antitumor therapy. Identification of clinical prognostic indicators is therefore needed. Although the C-reactive protein/albumin ratio (CAR) has been used to predict the prognosis of many types of malignancy, its utility in patients with MPM is unknown.MethodsThe data of 100 patients diagnosed as having MPM from 1995 to 2015 at the National Kyushu Cancer Center and Kyushu University were analyzed. The CAR was calculated as serum C-reactive protein concentration divided by albumin concentration. A cutoff for CAR was set at 0.58 according to a receiver operating characteristics curve for 1-year survival.ResultsThirty-five of the 100 (35.0%) patients were classified as having a high CAR. A high CAR was significantly associated with advanced clinical stage (p < 0.001) and chemotherapy alone (p = 0.002). Patients with a high CAR had significantly shorter overall survival (OS) (p < 0.001) and disease- or progression-free survival (DFS/PFS) (p < 0.001). These associations between CAR and prognosis remained significant after propensity score-matching. In multivariate analysis, a high CAR was an independent predictor of shorter OS and DFS/PFS (p = 0.003 and p = 0.008, respectively). Multivariate analyses of the subgroups of patients who had received chemotherapy and of patients who had undergone surgery also showed that a high CAR was an independent predictor of shorter OS and DFS/PFS.ConclusionsCAR is an independent predictor of prognosis in MPM patients. This prognostic index contributes to clinicians’ ability to predict benefit from treatment. Further larger, prospective studies are necessary to validate these findings.
This paper references
10.1158/1078-0432.CCR-11-2375
New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment
M. Ladanyi (2012)
10.1172/JCI32533
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.
P. Sansone (2007)
10.1186/1477-7819-8-85
The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer
O. Kemik (2010)
10.1038/s41598-017-03153-6
Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
Junjie Hang (2017)
10.1016/S1470-2045(17)30459-X
Radiotherapy for the treatment of malignant pleural mesothelioma.
M. Perrot (2017)
10.1016/j.jtho.2015.11.005
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
F. Galateau-Sallé (2016)
10.1016/J.CLIM.2005.08.004
C-reactive protein: ligands, receptors and role in inflammation.
L. Marnell (2005)
10.3978/j.issn.2072-1439.2015.11.15
Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy.
T. Tagawa (2015)
10.1093/carcin/bgu227
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
F. Baumann (2015)
10.1080/10937404.2016.1193361
Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles
P. Andujar (2016)
10.1093/dote/dox107
C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
Y. Otowa (2017)
10.7861/CLINMEDICINE.9-1-30
Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome.
Emily Fairclough (2009)
10.21037/jtd.2017.07.108
Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma.
G. Toyokawa (2017)
10.1111/dote.12482
Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
Y. Baba (2017)
10.1016/S0022-5223(96)70342-2
The importance of surgical staging in the treatment of malignant pleural mesothelioma.
V. Rusch (1996)
10.1097/JTO.0b013e31822a3740
Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy
S. Kao (2011)
10.1016/S0169-5002(01)00257-4
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma.
G. Ceresoli (2001)
10.2214/AJR.172.4.10587144
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
R. Heelan (1999)
10.2307/2530120
A qualitative discrepancy between censored data rank tests.
R. Prentice (1979)
temporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma
A Bille (2016)
10.1056/NEJM199902113400607
Acute-phase proteins and other systemic responses to inflammation.
C. Gabay (1999)
10.3748/WJG.V10.I8.1115
C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.
N. Ilhan (2004)
10.21873/ANTICANRES.11625
Significance of the Preoperative CONUT Score in Predicting Postoperative Disease-free and Overall Survival in Patients with Lung Adenocarcinoma with Obstructive Lung Disease.
Takaki Akamine (2017)
10.1016/S0003-4975(03)00010-9
The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma.
J. H. Schouwink (2003)
10.1016/j.critrevonc.2016.08.011
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?
G. Bronte (2016)
10.1097/MD.0000000000006848
Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy
Y. W. Koh (2017)
10.1016/j.amjsurg.2017.08.016
Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma.
K. Arima (2018)
10.1007/s13277-014-1938-5
Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma
Zhou-Hong Yao (2014)
10.1097/JTO.0b013e31823f45c1
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
D. Pinato (2012)
10.3978/j.issn.2225-319X.2012.10.02
Inflammation in malignant mesothelioma - friend or foe?
Anthony Linton (2012)
10.1200/JCO.1998.16.1.145
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
D. Curran (1998)
10.1016/j.ccm.2012.12.005
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
A. Haas (2013)
10.1016/j.lungcan.2015.07.014
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.
T. Yamagishi (2015)
10.1158/1078-0432.CCR-10-2245
High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
S. Kao (2010)
10.1016/j.jtho.2015.10.003
Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma
A. Billè (2016)
10.1038/nrclinonc.2015.105
Inflammation and cancer: advances and new agents
S. Crusz (2015)
10.1007/s00432-013-1523-0
Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma
Zhou-Hong Yao (2013)
10.1097/SLA.0000000000002252
Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer
Y. Nakashima (2018)
10.21873/ANTICANRES.11372
The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
F. Shoji (2017)
10.21873/anticanres.12022
Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
S. Ide (2017)
10.1038/bjc.2014.312
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey
G. Ceresoli (2014)
10.1371/journal.pone.0059321
C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients
O. Ranzani (2013)
10.1016/j.lungcan.2016.05.010
Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
F. Shoji (2016)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1158/1940-6207.CAPR-15-0347
Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma
Yuwaraj Kadariya (2016)
10.1186/s12885-017-3220-x
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
Y. Liu (2017)
10.1016/j.ccr.2009.01.001
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.
S. Grivennikov (2009)
10.1016/j.cllc.2017.01.008
The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma
Shinkichi Takamori (2017)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar